Nemaura Medical Inc. [NASDAQ: NMRD] stock went on an upward path that rose over 135.32% on Wednesday, amounting to a one-week price increase of more than 104.44%. The company report on May 5, 2021 that Nemaura Medical Announces Order for 200,000 sugarBEAT® Sensors.
Based on the success of the soft launch in the U.K., the Company is advancing discussions for joint launches in Germany, Saudi Arabia and UAE.
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announced receipt of a purchase order for 5,000 sugarBEAT® transmitters and 200,000 sugarBEAT® sensors from its U.K. licensee, DB Ethitronix Ltd, with an additional rolling monthly purchase order forecast for the next 24 months of 15,000 transmitters and 2.1 million sensors, with an option to increase volumes based on customer response.
Over the last 12 months, NMRD stock rose by 111.47%. The average equity rating for NMRD stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $249.96 million, with 22.92 million shares outstanding and 8.80 million shares in the current float. Compared to the average trading volume of 225.45K shares, NMRD stock reached a trading volume of 55575786 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Nemaura Medical Inc. [NMRD]:
The Average True Range (ATR) for Nemaura Medical Inc. is set at 0.95 The Price to Book ratio for the last quarter was 24.58, with the Price to Cash per share for the same quarter was set at 0.66.
NMRD Stock Performance Analysis:
Nemaura Medical Inc. [NMRD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 104.44. With this latest performance, NMRD shares gained by 52.76% in over the last four-week period, additionally plugging by 216.91% over the last 6 months – not to mention a rise of 111.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMRD stock in for the last two-week period is set at 77.39, with the RSI for the last a single of trading hit 84.39, and the three-weeks RSI is set at 71.98 for Nemaura Medical Inc. [NMRD]. The present Moving Average for the last 50 days of trading for this stock 6.87, while it was recorded at 6.03 for the last single week of trading, and 5.29 for the last 200 days.
Insight into Nemaura Medical Inc. Fundamentals:
Return on Total Capital for NMRD is now -1,045.67, given the latest momentum, and Return on Invested Capital for the company is -910.37. Return on Equity for this stock declined to -910.37, with Return on Assets sitting at -139.05.
Reflecting on the efficiency of the workforce at the company, Nemaura Medical Inc. [NMRD] managed to generate an average of -$244,717 per employee.Nemaura Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.60 and a Current Ratio set at 3.80.
Nemaura Medical Inc. [NMRD] Insider Position Details
There are presently around $7 million, or 6.10% of NMRD stock, in the hands of institutional investors. The top three institutional holders of NMRD stocks are: SABBY MANAGEMENT, LLC with ownership of 494,297, which is approximately -19.465% of the company’s market cap and around 61.63% of the total institutional ownership; BLACKROCK INC., holding 366,195 shares of the stock with an approximate value of $1.72 million in NMRD stocks shares; and VANGUARD GROUP INC, currently with $0.68 million in NMRD stock with ownership of nearly 2.098% of the company’s market capitalization.
Positions in Nemaura Medical Inc. stocks held by institutional investors increased at the end of June and at the time of the June reporting period, where 18 institutional holders increased their position in Nemaura Medical Inc. [NASDAQ:NMRD] by around 94,750 shares. Additionally, 11 investors decreased positions by around 227,365 shares, while 7 investors held positions by with 1,063,754 shares. The mentioned changes placed institutional holdings at 1,385,869 shares, according to the latest SEC report filing. NMRD stock had 6 new institutional investments in for a total of 37,761 shares, while 4 institutional investors sold positions of 90,680 shares during the same period.